期刊文献+

HPLC-DAD测定利培酮中有关物质 被引量:4

Determination of Related Substances in Risperidone by HPLC-DAD
原文传递
导出
摘要 运用二极管阵列检测器结合峰纯度分析建立利培酮有关物质HPLC的测定方法。采用C18色谱柱(Kromasil,C18,5μm,4.6×200mm),以1.0%三乙胺缓冲溶液(以磷酸调节pH值至3.0)∶乙腈(70∶30)为流动相,流速为0.8mL/min,柱温为30℃,检测波长为260nm。利培酮与有关物质分离良好,原料1、中间体1、中间体2以及利培酮检出限分别为0.4、4、0.4、0.6ng。二极管阵列检测器结合峰纯度分析可用于HPLC测定利培酮有关物质时色谱条件的选择和评价,本方法简单、快速、专属性好、灵敏度高。 A new HPLC method to determine related substances in risperidone by DAD and peak purity analysis was established,using C18 column(Kromasil,C18,5μm,4.6×200mm),acetonitrile-1% triethylamine buffer(30:70)(adjust pH to 3.0 by phosphoric acid)as mobile phase.The flow rate is 0.8mL/min;the column oven temperature is 30℃;the detection wavelength is 260nm.Risperidone and related substances are well separated; the LOD of raw material 1,intermediate 1,and intermediate 2 were 0.4,4,0.4,and 0.6ng.DAD and peak purity analysis is useful for evaluation of determination of related substances in risperidone by HPLC; the method is simple,fast,specific and sensitive.
作者 曹天海
出处 《光谱实验室》 CAS CSCD 北大核心 2010年第4期1473-1476,共4页 Chinese Journal of Spectroscopy Laboratory
关键词 高效液相色谱法 二极管阵列检测器 峰纯度分析 利培酮 有关物质 HPLC DAD Peak Purity Analysis Risperidone Related Substance
  • 相关文献

参考文献4

  • 1Papadoyannis I N,Peak H G.Purity Determination with a Diode Array Detector[J].J.Liq.Chromatogr.Rdat.Technol.,2004,27(6):1083-1092.
  • 2欧洲药典会.欧洲药典[M].第5版.Strasbourg:European Directorate for the Quality of Medicines & Health Care,2004.
  • 3国家食品药品管理局.利培酮片质量标准[S].WS1-(X-056)-2003Z.北京:国家食品药品管理局,2003.
  • 4Raggi M A,Bugamelli F,Sabbioni C et al.HPLC-DAD Determination of Plasma Levels of the Antipsychotic Risperidone and ItsMain Metabolite for Toxicological Purposes[J].J.Sep.Sci.,2005,28(3):245-250.

同被引文献25

  • 1陈钧,高小玲,蒋新国.高效液相色谱法测定利培酮片含量及有关物质[J].中国现代应用药学,2004,21(4):302-303. 被引量:5
  • 2张凤林.新型非典型抗精神病药——索乐(利培酮片)[J].中南药学,2006,4(3):237-239. 被引量:4
  • 3林治光,李华芳,翁毅仁,朱砾,蒋继承,庄冬梅,顾牛范.HPLC-电化学检测法测定人血清中利培酮及9-羟利培酮浓度[J].四川精神卫生,2007,20(2):65-68. 被引量:10
  • 4Bharathi CH, Chary DK, Kumar MS, et al. Identification, isolation and characterization of potential degradation product in risperidone tablets [ J ]. Journal of Pharmaceutical and Biomedical Analysis, 2008,46(1 ) :165 - 169.
  • 5Bladania SL, Bhatt KK, Mehta RS, et al. RP-HPLC estimation of risperidone in tablet dosage forms[ J]. Indian Journal of Pharmaceu- tical Sciences ,2005,70 (4) :494 - 497.
  • 6Tomar RS ,Joseph TJ,Murthy AS,et al. Identification and character-ization of major degradation products of risperidone in bulk drug and pharmaceutical dosage forms [ J ]. Journal of Pharmaceutical and Bio- medical Analysis,2004,36 ( 1 ) : 231 - 235.
  • 7E1-Sherif ZA, E1-Zeany B, E1-Houssini OM. High performance liquid chromatographic and thin layer densitometric methods for the deter- mination of risperidone in the presence of its degradation products in bulk powder and in tablets[ J]. Journal of Pharmaceutical and Bio- medical Analysis,2005,36 ( 5 ) :975 - 981.
  • 8国家药典会.中华人民共和国药典.临床用药须知[s].2010年版,北京:中国医药科技出版社,201l:520-530.
  • 9王 萍.利培酮片的质量研究与技术标准制定[D]天津:天津大学,2003.
  • 10邱小梅,罗晓东.RP-高效液相色谱法测定利培酮片剂含量[J].现代医药卫生,2009,25(2):214-214. 被引量:2

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部